State Street’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.39B Buy
61,741,014
+80,856
+0.1% +$7.75M 0.19% 94
2025
Q4
$5.97B Buy
61,660,158
+1,199,621
+2% +$117M 0.2% 91
2025
Q3
$5.8B Buy
60,460,537
+625,992
+1% +$57.5M 0.2% 94
2025
Q2
$5.26B Sell
59,834,545
-210,216
-0.4% -$17.8M 0.2% 100
2025
Q1
$5.44B Sell
60,044,761
-392,702
-0.6% -$35.1M 0.22% 89
2024
Q4
$4.87B Sell
60,437,463
-293,904
-0.5% -$25.4M 0.19% 92
2024
Q3
$5.51B Buy
60,731,367
+520,027
+0.9% +$43.7M 0.22% 78
2024
Q2
$4.78B Buy
60,211,340
+141,196
+0.2% +$11.6M 0.21% 87
2024
Q1
$5.28B Sell
60,070,144
-845,985
-1% -$72.2M 0.24% 76
2023
Q4
$5.06B Buy
60,916,129
+1,425,493
+2% +$109M 0.25% 74
2023
Q3
$4.7B Sell
59,490,636
-656,225
-1% -$54.9M 0.26% 70
2023
Q2
$5.34B Buy
60,146,861
+175,765
+0.3% +$15.1M 0.28% 68
2023
Q1
$4.88B Sell
59,971,096
-57,955
-0.1% -$4.72M 0.28% 73
2022
Q4
$4.71B Buy
60,029,051
+1,039,338
+2% +$84.2M 0.28% 72
2022
Q3
$4.8B Buy
58,989,713
+928,929
+2% +$83.5M 0.3% 62
2022
Q2
$5.25B Sell
58,060,784
-443,400
-0.8% -$44.9M 0.31% 64
2022
Q1
$6.53B Buy
58,504,184
+529,855
+0.9% +$56M 0.32% 62
2021
Q4
$6.03B Buy
57,974,329
+1,591,381
+3% +$184M 0.29% 66
2021
Q3
$7.1B Buy
56,382,948
+534,899
+1% +$69.2M 0.38% 56
2021
Q2
$6.97B Buy
55,848,049
+1,128,738
+2% +$142M 0.37% 55
2021
Q1
$6.5B Sell
54,719,311
-1,215,385
-2% -$142M 0.37% 58
2020
Q4
$6.58B Sell
55,934,696
-2,059,801
-4% -$227M 0.4% 52
2020
Q3
$6.06B Sell
57,994,497
-875,532
-1% -$87.9M 0.41% 49
2020
Q2
$5.43B Buy
58,870,029
+567,437
+1% +$54.4M 0.39% 51
2020
Q1
$5.29B Buy
58,302,592
+439,413
+0.8% +$46.7M 0.46% 42
2019
Q4
$6.6B Buy
57,863,179
+567,864
+1% +$62.3M 0.45% 39
2019
Q3
$6.25B Sell
57,295,315
-396,188
-0.7% -$41.3M 0.47% 38
2019
Q2
$5.62B Buy
57,691,503
+64,328
+0.1% +$5.87M 0.42% 44
2019
Q1
$5.28B Buy
57,627,175
+2,681,245
+5% +$240M 0.41% 45
2018
Q4
$5.03B Sell
54,945,930
-557,054
-1% -$52.1M 0.46% 43
2018
Q3
$5.46B Buy
55,502,984
+2,419,276
+5% +$224M 0.42% 46
2018
Q2
$4.54B Sell
53,083,708
-502,787
-0.9% -$42M 0.38% 48
2018
Q1
$4.3B Sell
53,586,495
-4,523,588
-8% -$373M 0.37% 50
2017
Q4
$4.69B Sell
58,110,083
-1,336,732
-2% -$107M 0.38% 50
2017
Q3
$4.62B Sell
59,446,815
-2,081,823
-3% -$173M 0.4% 49
2017
Q2
$5.46B Sell
61,528,638
-1,560,136
-2% -$132M 0.48% 41
2017
Q1
$5.08B Sell
63,088,774
-952,126
-1% -$74.4M 0.45% 43
2016
Q4
$4.56B Buy
64,040,900
+1,481,108
+2% +$116M 0.43% 45
2016
Q3
$5.41B Buy
62,559,792
+7,603,858
+14% +$663M 0.55% 37
2016
Q2
$4.77B Sell
54,955,934
-157,872
-0.3% -$12.8M 0.51% 40
2016
Q1
$4.13B Sell
55,113,806
-1,176,598
-2% -$88.6M 0.45% 46
2015
Q4
$4.33B Sell
56,290,404
-71,215
-0.1% -$5.36M 0.47% 42
2015
Q3
$3.77B Sell
56,361,619
-667,389
-1% -$49.2M 0.44% 48
2015
Q2
$4.23B Sell
57,029,008
-2,609,925
-4% -$199M 0.45% 48
2015
Q1
$4.65B Buy
59,638,933
+14,830,286
+33% +$1.12B 0.48% 45
2014
Q4
$3.24B Buy
44,808,647
+640,497
+1% +$44.5M 0.32% 66
2014
Q3
$2.74B Buy
44,168,150
+201,171
+0.5% +$12.8M 0.29% 70
2014
Q2
$2.8B Buy
43,966,979
+614,501
+1% +$37.3M 0.3% 68
2014
Q1
$2.67B Sell
43,352,478
-2,060,832
-5% -$120M 0.3% 67
2013
Q4
$2.61B Buy
45,413,310
+925,250
+2% +$52.5M 0.29% 72
2013
Q3
$2.37B Sell
44,488,060
-1,014,119
-2% -$54.6M 0.29% 70
2013
Q2
$2.34B Buy
+45,502,179
New +$2.25B 0.31% 66

Other funds holding MDT

State Street's MDT Position: Q1 2026 in Review

State Street increased its Medtronic (MDT) stake by 0.13% in Q1 2026, buying an estimated $7.75M and bringing the position to 61,741,014 shares worth $5.39B. The position accounts for 0.19% of the portfolio, ranked #94.

State Street first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.1B in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • State Street held 61,741,014 shares of Medtronic worth $5.39B as of Q1 2026.
  • State Street bought 80,856 Medtronic shares in Q1 2026, an estimated $7.75M.
  • Medtronic made up 0.19% of State Street's portfolio in Q1 2026, its #94 holding.
  • State Street first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • State Street's Medtronic position peaked at $7.1B in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.